Stay updated on Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference3%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the safety and efficacy of anti PD-1 antibody with radiation therapy for HER2-negative metastatic breast cancer, while a new version number has been added.SummaryDifference29%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.